Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
A., Harper, J
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
Background references Z
Stability and binding affinity changes relative to the wild type were calculated for all possible single variants with pAcF substitution in nanobodies PV2 and PV3 using Rosetta Cartesian_ddG and Flex_ddG (Fig
For most users it is a tolerability nuisance rather than a safety concern, and it resolves on lowering or stopping the dose
Wright SS, Kumari P, Fraile-greda V, Wang C, Shivcharan S, Kappelhoff S, et al
US$ 28.28
US$ 24.78
US$ 25.12
US$ 22.48
US$ 28.24
US$ 25.94
US$ 27.00
